Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-048525
Filing Date
2009-03-09
Accepted
2009-03-09 16:16:09
Documents
12
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 964940
2 AGREEMENT FOR TERMINATION OF LEASE - ARE-SAN FRANCISCO NO. 41, LLC dex1028.htm EX-10.28 63021
3 AGREEMENT FOR TERMINATION OF LEASE - BMR-BRIDGEVIEW TECHNOLOGY PARK II, LLC dex1029.htm EX-10.29 58669
4 AGREEMENT FOR TERMINATION OF LEASE - BMR-BRIDGEVIEW TECHNOLOGY PARK, LLC dex1030.htm EX-10.30 28990
5 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 43440
6 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1557
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 11626
8 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex311.htm EX-31.1 9766
9 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex312.htm EX-31.2 9748
10 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 2748
11 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 2737
12 GRAPHIC g95678g29w95.jpg GRAPHIC 44673
  Complete submission text file 0001193125-09-048525.txt   1260398
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 525 SOUTH SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BOULEVARD SUITE 525 SOUTH SAN FRANCISCO CA 94080 650-266-3000
CELL GENESYS INC (Filer) CIK: 0000865231 (see all company filings)

EIN.: 943061375 | State of Incorp.: DE | Fiscal Year End: 1017
Type: 10-K | Act: 34 | File No.: 000-19986 | Film No.: 09666295
SIC: 2834 Pharmaceutical Preparations